*****
Impactiviti has launched a new venture, and we’d like to ask for your help to make it a success! Introducing the Impactiviti Talent Network – on-line job search joined to social networking. This can help you as a job seeker, AND as a company posting openings!
TODAY’S NEWS:
Head of Pfizer R&D pulls up stakes, goes to AstraZeneca.
Pfizer‘s Inspra meets primary study goals early – Pfizer reported Thursday that it plans to stop enrolling patients ahead of schedule in a late-stage trial of Inspra (eplerenone) after those taking the drug experienced a significant reduction in risk of cardiovascular death or heart failure hospitalisation compared with those receiving placebo...more
Sanofi‘s prostate cancer drug: 28% survival improvement in study - Sanofi-Aventis’ cabazitaxel candidate prostate cancer drug combined with prednisone reduced the risk of death by 28 percent compared with another treatment, the outcome of a final-stage trial showed. The French drugmaker said on Thursday that the combination of the treatments led to an improved median overall survival of 15.1 months against 12.7 months in patients who took a chemotherapy of mitoxantrone with prednisone/prednisolone…more
Intermune to lay off 40% of workforce – InterMune Inc. said it will fire about 60 employees, or 40 percent of its workforce, to reduce costs after the U.S. Food and Drug Administration rejected the company’s lung drug earlier this month...more
RECOMMENDED
Facebook page development/monitoring. If your marketing group is thinking about Facebook as a platform, we have the development and management partners you need for social media. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
PLUS
I don’t usually wander into political waters on this blog. But I found this article to be so compelling and cogent, I had to share. America’s New Culture War: Free Enterprise vs. Government Control. Worth the read!
JUST FOR FUN
Splash of yellow. From my backyard. And, daisies in the evening.
———-
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Visit the Impactiviti Job Board
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
*****
